Nucleofection
Nucleofection is an electroporation-based transfection method which enables transfer of nucleic acids such as DNA and RNA into cells by applying a specific voltage and reagents. Nucleofection, also referred to as Nucleofector Technology, was invented by the biotechnology company Amaxa. “Nucleofector” and “nucleofection” are trademarks owned by Lonza Cologne AG, part of the Lonza Group.